Cargando…
Head-to-head comparison of (18)F-FAPI and (18)F-FDG PET/CT in staging and therapeutic management of hepatocellular carcinoma
BACKGROUND: Fluorine 18 ((18)F) fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) has limitations in staging hepatocellular carcinoma (HCC). The recently introduced (18)F-labeled fibroblast-activation protein inhibitor (FAPI) has shown promising prospects in detectio...
Autores principales: | Zhang, Jing, Jiang, Shuqin, Li, Mengsi, Xue, Haibao, Zhong, Xi, Li, Shuyi, Peng, Hao, Liang, Jiuceng, Liu, Zhidong, Rao, Songquan, Chen, Haipeng, Cao, Zewen, Gong, Yuanfeng, Chen, Guoshuo, Zhang, Rusen, Zhang, Linqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614420/ https://www.ncbi.nlm.nih.gov/pubmed/37899452 http://dx.doi.org/10.1186/s40644-023-00626-y |
Ejemplares similares
-
Head-to-Head Intra-Individual Comparison of Biodistribution and Tumor Uptake of [(18)F]FAPI-74 with [(18)F]FDG in Patients with PDAC: A Prospective Exploratory Study
por: Novruzov, Emil, et al.
Publicado: (2023) -
Head-to-Head Comparison of Fibroblast Activation Protein Inhibitors (FAPI) Radiotracers versus [(18)F]F-FDG in Oncology: A Systematic Review
por: Treglia, Giorgio, et al.
Publicado: (2021) -
Head-to-head Intra-individual Comparison of [(68)Ga]-FAPI and [(18)F]-FDG PET/CT in Patients with Bladder Cancer
por: Novruzov, E., et al.
Publicado: (2022) -
Head-to-Head Comparison of [(68) Ga]Ga-FAPI-46-PET/CT and [(18)F]F-FDG-PET/CT for Radiotherapy Planning in Head and Neck Cancer
por: Wegen, Simone, et al.
Publicado: (2022) -
Head-to-Head Comparison between [(68)Ga]Ga-DOTA.SA.FAPi and [(18)F]F-FDG PET/CT Imaging in Patients with Breast Cancer
por: Ballal, Sanjana, et al.
Publicado: (2023)